IL1B and pneumonia: This results in decreased production of pro-inflammatory cytokines like interleukin (IL)-1β and tumor necrosis factor (TNF)-α, while increasing the production of the anti-inflammatory cytokine IL-10, ultimately leading to immunosuppression and the exacerbation of pneumonia (13, 14).